Journal
EMERGING INFECTIOUS DISEASES
Volume 21, Issue 11, Pages 2040-2044Publisher
CENTERS DISEASE CONTROL
DOI: 10.3201/eid2111.140780
Keywords
-
Categories
Ask authors/readers for more resources
Three years after a 7-valent pneumococcal conjugate vaccine was replaced by a 10-valent pneumococcal conjugate vaccine in the Netherlands, we observed a decrease in incidence of invasive pneumococcal disease caused by Streptococcus pneumoniae serotypes 1, 5, and 7F. Our data do not support or exclude cross-protection against serotype 19A.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available